Trans Genic

Trans Genic is a company listed under the stock ticker 2342 (JP).

View the org chart displaying its 5 main executives

Most searched biographies at Trans Genic

• Kenji Fukunaga, President, Chief Financial Officer, Representative...
• Yutaka Funabashi, Director
• Tamami Sakamoto, Director

Create your alert
to follow the executive moves at Trans Genic.

Trans Genic has 2,276 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Trans Genic

• https://www.transgenic.co.jp/pressrelease/pdf/20230210-2.pdf
• https://www.transgenic.co.jp/pressrelease/pdf/d4340f74b8cd743ede81bf90efdfba1e7ba7524c.pdf
• https://www.transgenic.co.jp/pressrelease/pdf/20221201.pdf

Social media about Trans Genic

• Trans Genic on Wikipedia, Google News & Yahoo Finance
• Trans Genic on LinkedIn, Twitter & YouTube

Call Trans Genic at +81 96...

View the org chart

Register to receive your alert

Report an error